10x Genomics Balance Sheet Health
Financial Health criteria checks 5/6
10x Genomics has a total shareholder equity of $718.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $922.9M and $204.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$371.81m |
Equity | US$718.83m |
Total liabilities | US$204.08m |
Total assets | US$922.91m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0A88's short term assets ($567.1M) exceed its short term liabilities ($108.7M).
Long Term Liabilities: 0A88's short term assets ($567.1M) exceed its long term liabilities ($95.3M).
Debt to Equity History and Analysis
Debt Level: 0A88 is debt free.
Reducing Debt: 0A88 has no debt compared to 5 years ago when its debt to equity ratio was 127.6%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0A88 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 0A88 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.